Interleukin-10-1082A/G polymorphism and inflammatory bowel disease susceptibility: A meta-analysis based on 17,585 subjects

Cytokine

Volumn 61, Issue 1, 2013, Pages 146-153

  Zhu, Hang ^a   Lei, Xun ^a   Liu, Qin ^a   Wang, Yang ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Crohn's disease; Interleukin 10; Meta analysis; Polymorphism; Ulcerative colitis

Indexed keywords

INTERLEUKIN 10;

ARTICLE; CROHN DISEASE; ENTERITIS; ETHNICITY; GENE; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; INTERLEUKIN 10 GENE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; ULCERATIVE COLITIS;

CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-10; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84869883011     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.09.009     Document Type: Article

References (49)

1. Loftus E.V. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 2004, 126:1504-1517.
2. Lakatos P.L. Recent trends in the epidemiology of inflammatory bowel diseases: up or down?. World J Gastroenterol 2006, 12:6102-6108.
3. Ouyang Q., Tandon R., Goh K.L., Ooi C.J., Oqata H., Fiocchi C. The emergence of inflammatory bowel disease in the Asian Pacific region. Curr Opin Gastroenterol 2005, 21:408-413.
4. Baumgart D.C., Carding S.R. Inflammatory bowel disease: cause and immunobiology. Lancet 2007, 369:1627-1640.
5. Bonner G.F. Current medical therapy for inflammatory bowel disease. South Med J 1996, 89:556-566.
6. Bouma G., Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003, 3:521-533.
7. Xavier R.J., Podolsky D.K. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007, 448:427-434.
8. Hugot J.P., Chamaillard M., Zouali H., Lesage S., Cézard J.P., Belaiche J., et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001, 411:599-603.
9. Hampe J., Cuthbert A., Croucher P.J., Mirza M.M., Mascheretti S., Fisher S., et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 2001, 357:1925-1928.
10. Ogura Y., Bonen D.K., Inohara N., Nicolae D.L., Chen F.F., Ramos R., et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001, 411:603-606.
11. Polgar N., Csongei V., Szabo M., Zambo V., Melegh B.I., Sumegi K., et al. Investigation of JAK2, STAT3 and CCR6 polymorphisms and their gene-gene interactions in inflammatory bowel disease. Int J Immunogenet 2012, 39:247-252.
12. Kim E.J., Chung W.C., Lee K.M., Paik C.N., Jung S.H., Lee B.I., et al. Association between toll-like receptor/CD14 gene polymorphisms and inflammatory bowel disease in Korean population. J Korean Med Sci 2012, 27:72-77.
13. Haub S., Ritze Y., Bergheim I., Pabst O., Gershon M.D., Bischoff S.C. Enhancement of intestinal inflammation in mice lacking interleukin-10 by deletion of the serotonin reuptake transporter. Neurogastroenterol Motil 2010, 22:826-834.
14. Balish E., Warner T. Enterococcus faecalis induces inflammatory bowel disease in interleukin-10 knockout mice. Am J Pathol 2002, 160:2253-2257.
15. Schreiber S., Heinig T., Thiele H.G., Raedler A. Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease. Gastroenterology 1995, 108:1434-1444.
16. Correa I., Veny M., Esteller M., Piqué J.M., Yagüe J., Panés J., et al. Defective IL-10 production in severe phenotypes of Crohn's disease. J Leukoc Biol 2009, 85:896-903.
17. Mäurer M., Kruse N., Giess R., Toyka K.V., Rieckmann P. Genetic variation at position -1082 of the interleukin 10 (IL10) promotor and the outcome of multiple sclerosis. J Neuroimmunol 2000, 104:98-100.
18. Zhang J., Zhang Y., Jin J., Li M., Xie K., Wen C., et al. The -1082A/G polymorphism in the interleukin-10 gene and the risk of rheumatoid arthritis: a meta-analysis. Cytokine 2011, 56:351-355.
19. Lee Y.H., Choi S.J., Ji J.D., Song G.G. Associations between interleukin-10 polymorphisms and susceptibility to psoriasis: a meta-analysis. Inflamm Res 2012, 61:657-663.
20. Nath S.K., Harley J.B., Lee Y.H. Polymorphisms of complement receptor 1 and interleukin-10 genes and systemic lupus erythematosus: a meta-analysis. Hum Genet 2005, 118:225-234.
21. Ahirwar D.K., Kesarwani P., Singh R., Ghoshal U.C., Mittal R.D. Role of tumor necrosis factor-alpha (C-863A) polymorphism in pathogenesis of inflammatory bowel disease in Northern India. J Gastrointest Cancer 2012, 43:196-204.
22. Andersen V., Ernst A., Christensen J., Østergaard M., Jacobsen B.A., Tjønneland A., et al. The polymorphism rs3024505 proximal to IL-10 is associated with risk of ulcerative colitis and Crohn's disease in a Danish case-control study. BMC Med Genet 2010, 11:82.
23. Balding J., Livingstone W.J., Conroy J., Mynett-Johnson L., Weir D.G., Mahmud N., et al. Inflammatory bowel disease: the role of inflammatory cytokine gene polymorphisms. Mediators Inflamm 2004, 13:181-187.
24. Cantor M.J., Nickerson P., Bernstein C.N. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease. Am J Gastroenterol 2005, 100:1134-1142.
25. Castro-Santos P., Suarez A., López-Rivas L., Mozo L., Gutierrez C. TNFalpha and IL-10 gene polymorphisms in inflammatory bowel disease. Association of -1082AA low producer IL-10 genotype with steroid dependency. Am J Gastroenterol 2006, 101:1039-1047.
26. Celik Y., Dagli U., Kiliç M.Y., Törüner M., Ozen S.C., Ozkan M., et al. Cytokine gene polymorphisms in Turkish patients with inflammatory bowel disease. Scand J Gastroenterol 2006, 41:559-565.
27. Fernandez L., Martinez A., Mendoza J.L., Urcelay E., Fernandez-Arguero M., Garcia-Paredes J., et al. Interleukin-10 polymorphisms in Spanish patients with IBD. Inflamm Bowel Dis 2005, 11:739-743.
28. Fowler E.V., Eri R., Hume G., Johnstone S., Pandeya N., Lincoln D., et al. TNFalpha and IL-10 SNPs act together to predict disease behaviour in Crohn's disease. J Med Genet 2005, 42:523-528.
29. Franke A., Balschun T., Karlsen T.H., Sventoraityte J., Nikolaus S., Mayr G., et al. Sequence variants in IL-10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat Genet 2008, 40:1319-1323.
30. Garza-González E., Pérez-Pérez G.I., Mendoza-Ibarra S.I., Flores-Gutiérrez J.P., Bosques-Padilla F.J. Genetic risk factors for inflammatory bowel disease in a North-eastern Mexican population. Int J Immunogenet 2010, 37:355-359.
31. Hong J., Leung E., Fraser A.G., Merriman T.R., Vishnu P., Krissansen G.W. IL4, IL10, IL16, and TNF polymorphisms in New Zealand Caucasian Crohn's disease patients. Int J Colorectal Dis 2008, 23:335-337.
32. Klein W., Tromm A., Griga T., Fricke H., Folwaczny C., Hocke M., et al. The IL-10 gene is not involved in the predisposition to inflammatory bowel disease. Electrophoresis 2000, 21:3578-3582.
33. Kim T.H., Kim B.G., Shin H.D., Kim J.W., Kim C.G., Kim J.S., et al. Tumor necrosis factor-alpha and interleukin-10 gene polymorphisms in Korean patients with inflammatory bowel disease. Korean J Gastroenterol 2003, 42:377-386.
34. Klausz G., Molnár T., Nagy F., Gyulai Z., Boda K., Lonovics J., et al. Polymorphism of the heat-shock protein gene Hsp70-2, but not polymorphisms of the IL-10 and CD14 genes, is associated with the outcome of Crohn's disease. Scand J Gastroenterol 2005, 40:1197-1204.
35. Sanchez R., Levy E., Costea F., Sinnett D. IL-10 and TNF-alpha promoter haplotypes are associated with childhood Crohn's disease location. World J Gastroenterol 2009, 15:3776-3782.
36. Tagore A., Gonsalkorale W.M., Pravica V., Hajeer A.H., McMahon R., Whorwell P.J., et al. Interleukin-10 (IL-10) genotypes in inflammatory bowel disease. Tissue Antigens 1999, 54:386-390.
37. Tedde A., Laura Putignano A., Bagnoli S., Congregati C., Milla M., Sorbi S, et al. Interleukin-10 promoter polymorphisms influence susceptibility to ulcerative colitis in a gender-specific manner. Scand J Gastroenterol 2008, 43:712-718.
38. Wang A.H., Lam W.J., Han D.Y., Ding Y., Hu R., Fraser A.G., et al. The effect of IL-10 genetic variation and interleukin 10serum levels on Crohn's disease susceptibility in a New Zealand population. Hum Immunol 2011, 72:431-435.
39. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
40. Parkes M., Satsangi J., Jewell D. Contribution of the IL-2 and IL-10 genes to inflammatory bowel disease (IBD) susceptibility. Clin Exp Immunol 1998, 113:28-32.
41. Aithal G.P., Craggs A., Day C.P., Welfare M., Daly A.K., Mansfield J.C., et al. Role of polymorphisms in the interleukin-10 gene in determining disease susceptibility and phenotype in inflammatory bowel disease. Dig Dis Sci 2001, 46:1520-1525.
42. Amre D.K., Mack D.R., Morgan K., Israel D., Lambrette P., Costea I., et al. Interleukin 10 (IL-10) gene variants and susceptibility for paediatric onset Crohn's disease. Aliment Pharmacol Ther 2009, 29:1025-1031.
43. Festen E.A., Stokkers P.C., van Diemen C.C., van Bodegraven A.A., Boezen H.M., Crusius B.J., et al. Genetic analysis in a Dutch study sample identifies more ulcerative colitis susceptibility loci and shows their additive role in disease risk. Am J Gastroenterol 2010, 105:395-402.
44. Marrakchi R., Moussa A., Ouerhani S., Bougatef K., Bouhaha R., Messai Y., et al. Interleukin 10 promoter region polymorphisms in inflammatory bowel disease in Tunisian population. Inflamm Res 2009, 58:155-160.
45. Shi J., Zhou L., Zhernakova A., Qian J., Zhu F., Sun G., et al. Haplotype-based analysis of ulcerative colitis risk loci identifies both IL2 and IL21 as susceptibility genes in Han Chinese. Inflamm Bowel Dis 2011, 17:2472-2479.
46. Koss K., Satsangi J., Fanning G.C., Welsh K.I., Jewell D.P. Cytokine (TNF alpha, LT alpha and IL-10) polymorphisms in inflammatory bowel disease and normal controls: differential effects on production and allele frequencies. Genes Immun 2000, 1:185-190.
47. Gibson A.W., Edberg J.C., Wu J., Westendorp R.G., Huizinga T.W., Kimberly R.P. Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J Immunol 2001, 166:3915-3922.
48. Ouma C., Davenport G.C., Were T., Otieno M.F., Hittner J.B., Vulule J.M., et al. Haplotypes of IL-10 promoter variants are associated with susceptibility to severe malaria anemia and functional changes in IL-10 production. Hum Genet 2008, 124:515-524.
49. Martinez A., Pascual M., Pascual-Salcedo D., Balsa A., Martin J., de la Concha E.G. Genetic polymorphisms in Spanish rheumatoid arthritis patients: an association and linkage study. Genes Immunol 2003, 4:117-121.